SAN ANTONIO, April 11, 2019 /PRNewswire/ -- Fe3 Medical, the creators of a transdermal patch for the treatment of iron deficiency anemia, today announced the results from its first human study of the ...

In the late 1980s, General Motors was eager to prove to American car shoppers that its upscale sporty machinery was every bit as well-engineered and prestigious as the stuff coming across the Atlantic ...

In the 1980s, Oldsmobile used a handful of production-based prototypes as test beds for future performance and engineering features. These cars were designated FE3-X, a nod to the FE3 option code for ...

Patch-like wearables are becoming increasingly popular in medtech. The latest device to employ such a design and make medtech headlines is transdermal patch being developed by Fe3 Medical. San Antonio ...

Tests showed rapid rises in serum iron levels during the first four hours of treatment, with a decline and return to baseline levels within 24 hours. (Pixabay) () For many people with Crohn’s disease, ...

The state of Texas has invested $3.5 million in a San Antonio medical technology company developing a skin patch to provide iron to patients suffering from iron-deficiency anemia. The state’s latest ...

San Antonio-based Fe3 Medical disclosed Wednesday it has raised $11 million from investors to fund clinical trials of a transdermal patch it has developed for patients suffering from iron-deficiency ...